Cetilistat (ATL -962), a novel lipase inhibitor: a 12 week randomised, placebo-controlled study of weight reduction in obese patients

Kopelman, PG, Bryson, A, Hickling, R, Rissanen, A, Rossner, S, Troubro, S and Valensi, P (2007) Cetilistat (ATL -962), a novel lipase inhibitor: a 12 week randomised, placebo-controlled study of weight reduction in obese patients. International Journal of Obesity, 31 (3). pp. 494-499.

Full text not available from this repository.
Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences
Depositing User: EPrints Services
Date Deposited: 25 Nov 2010 11:10
Last Modified: 28 Feb 2011 12:51
URI: https://ueaeprints.uea.ac.uk/id/eprint/13046
DOI:

Actions (login required)

View Item View Item